Annual report [Section 13 and 15(d), not S-K Item 405]

Summary of Significant Accounting Policies (Details Narrative)

v3.25.4
Summary of Significant Accounting Policies (Details Narrative)
12 Months Ended
Dec. 31, 2025
USD ($)
Integer
shares
Dec. 31, 2024
USD ($)
shares
DisclosureLineElements [Line Items]    
Asset impairment charge   $ 700,000
Accrued research costs $ 709,916 $ 610,648
Antidilutive shares | shares 29,000 3,000
Operating segment | Integer 1  
Reporting segment | Integer 1  
Research And Development Expenses [Member]    
DisclosureLineElements [Line Items]    
Prepaid expenses and other current assets $ 100,000 $ 300,000
Accrued research costs $ 400,000 $ 200,000